Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-35,000
Closed -$1.56M 6202
2020
Q4
$1.56M Buy
+35,000
New +$1.21M ﹤0.01% 3426
2020
Q1
Sell
-40,000
Closed -$2.73M 4159
2019
Q4
$2.73M Buy
40,000
+30,000
+300% +$1.88M ﹤0.01% 2405
2019
Q3
$479K Hold
10,000
﹤0.01% 3294
2019
Q2
$668K Sell
10,000
-15,000
-60% -$1.14M ﹤0.01% 3051
2019
Q1
$2.38M Buy
25,000
+17,000
+213% +$2.12M ﹤0.01% 2298
2018
Q4
$993K Sell
8,000
-2,000
-20% -$329K ﹤0.01% 2584
2018
Q3
$2.44M Buy
+10,000
New +$2.31M ﹤0.01% 2305
2018
Q1
Sell
-10,000
Closed -$1.19M 3850
2017
Q4
$1.19M Hold
10,000
﹤0.01% 2592
2017
Q3
$951K Buy
+10,000
New +$964K ﹤0.01% 2546

Other funds holding INGN

Israel Englander's INGN Position: Q2 2026 in Review

Israel Englander reduced its Inogen (INGN) stake by 73% in Q2 2026, selling an estimated $419K and leaving 23,568 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #5388.

Israel Englander first reported a position in INGN in Q1 2014 and has held it in 42 quarters since. The position peaked at $32.4M in Q4 2017. 128 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Israel Englander held 23,568 shares of Inogen worth $152K as of Q2 2026.
  • Israel Englander sold 63,382 Inogen shares in Q2 2026, an estimated $419K.
  • Inogen made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5388 holding.
  • Israel Englander first reported a position in Inogen in Q1 2014 and has held it in 42 quarters since.
  • Israel Englander's Inogen position peaked at $32.4M in Q4 2017.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.